UB560
TargetsActRIIA
IndicationsObesity
ClinicalCN - PCC
TherapeuticsMetabolic & Endocrinology
ModalitiesAntibody
Exclusive Summary
- • Higher binding affinity to ActRIIA compare with LEA102.
- • Fovarable druggability.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →